Literature DB >> 21584654

Estimating the number of persons with frontotemporal lobar degeneration in the US population.

David S Knopman1, Rosebud O Roberts.   

Abstract

There are many challenges for determining the prevalence and incidence of frontotemporal lobar degenerations (FTLD). Consequently, the number of cases of behavioral variant frontotemporal dementia (bvFTD) or primary progressive aphasia (PPA) in the USA is unknown. Our objective was to derive a consensus estimate of bvFTD and PPA prevalence and thereby to estimate the total number of these syndromes in the USA. We identified five prevalence and three incidence studies of FTLD based on passive surveillance and seven studies of survival in FTLD. Data from these studies were used to estimate the number of cases of PPA or bvFTD in the USA. Because prevalence and incidence estimates outside of the 45-64-year age range were either not available or widely divergent, we used data from clinical and pathological series to estimate the proportion of FTLD cases aged <45 or >64 years. The prevalence estimates in the age categories of 45-64 years old have ranged from 15 to 22 per 100,000 person-years in studies where both bvFTD and PPA were identified. The incidence estimates for the same age group ranged from 2.7 to 4.1 per 100,000 person-years. Using a survival rate of 6 to 9 years from onset and rates from the incidence studies, a calculated prevalence estimate (prevalence = incidence × duration) was similar to the previously reported prevalence rates. We estimated that 10% of cases were less than age 45 years and 30% were 65 years and older. We estimate that there are approximately 20,000 to 30,000 cases of the cognitive syndromes of FTLD in the USA. The main threat to the accuracy of the estimates is the difficulty in diagnosing the clinical syndromes that comprise the FTLD group of disorders.

Entities:  

Mesh:

Year:  2011        PMID: 21584654      PMCID: PMC3208074          DOI: 10.1007/s12031-011-9538-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  30 in total

1.  Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank.

Authors:  Warren W Barker; Cheryl A Luis; Alice Kashuba; Mercy Luis; Dylan G Harwood; David Loewenstein; Carol Waters; Pat Jimison; Eugene Shepherd; Steven Sevush; Neil Graff-Radford; Douglas Newland; Murray Todd; Bayard Miller; Michael Gold; Kenneth Heilman; Leilani Doty; Ira Goodman; Bruce Robinson; Gary Pearl; Dennis Dickson; Ranjan Duara
Journal:  Alzheimer Dis Assoc Disord       Date:  2002 Oct-Dec       Impact factor: 2.703

Review 2.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

Authors:  D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

3.  Rate of progression differs in frontotemporal dementia and Alzheimer disease.

Authors:  K Rascovsky; D P Salmon; A M Lipton; J B Leverenz; C DeCarli; W J Jagust; C M Clark; M F Mendez; D F Tang-Wai; N R Graff-Radford; D Galasko
Journal:  Neurology       Date:  2005-08-09       Impact factor: 9.910

4.  Frontotemporal lobar degeneration: demographic characteristics of 353 patients.

Authors:  Julene K Johnson; Janine Diehl; Mario F Mendez; John Neuhaus; Jill S Shapira; Mark Forman; Dennis J Chute; Erik D Roberson; Catherine Pace-Savitsky; Manuela Neumann; Tiffany W Chow; Howard J Rosen; Hans Forstl; Alexander Kurz; Bruce L Miller
Journal:  Arch Neurol       Date:  2005-06

Review 5.  Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

6.  Antemortem diagnosis of frontotemporal lobar degeneration.

Authors:  David S Knopman; Bradley F Boeve; Joseph E Parisi; Dennis W Dickson; Glenn E Smith; Robert J Ivnik; Keith A Josephs; Ronald C Petersen
Journal:  Ann Neurol       Date:  2005-04       Impact factor: 10.422

7.  Survival in frontotemporal dementia.

Authors:  J R Hodges; R Davies; J Xuereb; J Kril; G Halliday
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

8.  Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study.

Authors:  Sonia M Rosso; Laura Donker Kaat; Timo Baks; Marijke Joosse; Inge de Koning; Yolande Pijnenburg; Daniëlle de Jong; Dennis Dooijes; Wouter Kamphorst; Rivka Ravid; Martinus F Niermeijer; Frans Verheij; H P Kremer; Philip Scheltens; Cornelia M van Duijn; Peter Heutink; John C van Swieten
Journal:  Brain       Date:  2003-07-22       Impact factor: 13.501

9.  The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994.

Authors:  D S Knopman; R C Petersen; S D Edland; R H Cha; W A Rocca
Journal:  Neurology       Date:  2004-02-10       Impact factor: 9.910

10.  Clinicopathological correlates in frontotemporal dementia.

Authors:  John R Hodges; R Rhys Davies; John H Xuereb; Barney Casey; Melissa Broe; Thomas H Bak; Jillian J Kril; Glenda M Halliday
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

View more
  76 in total

1.  Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.

Authors:  David J Irwin; Alberto Lleó; Sharon X Xie; Corey T McMillan; David A Wolk; Edward B Lee; Viviana M Van Deerlin; Leslie M Shaw; John Q Trojanowski; Murray Grossman
Journal:  Ann Neurol       Date:  2017-08-19       Impact factor: 10.422

Review 2.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

3.  Occupational attainment influences survival in autopsy-confirmed frontotemporal degeneration.

Authors:  Lauren Massimo; Jarcy Zee; Sharon X Xie; Corey T McMillan; Katya Rascovsky; David J Irwin; Ann Kolanowski; Murray Grossman
Journal:  Neurology       Date:  2015-04-22       Impact factor: 9.910

Review 4.  Young-onset dementia epidemiology applied to neuropsychiatry practice.

Authors:  Bhargavi Devineni; Chiadi U Onyike
Journal:  Psychiatr Clin North Am       Date:  2015-03-26

5.  Targeting the low-hanging fruit of neurodegeneration.

Authors:  Amanda R Mason; Adam Ziemann; Steven Finkbeiner
Journal:  Neurology       Date:  2014-10-14       Impact factor: 9.910

6.  Frontotemporal Dementia: A Cross-Cultural Perspective.

Authors:  Chiadi U Onyike; Shunichiro Shinagawa; Ratnavalli Ellajosyula
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Hippocampal Sclerosis in Older Patients: Practical Examples and Guidance With a Focus on Cerebral Age-Related TDP-43 With Sclerosis.

Authors:  Matthew D Cykowski; Suzanne Z Powell; Paul E Schulz; Hidehiro Takei; Andreana L Rivera; Robert E Jackson; Gustavo Roman; Gregory A Jicha; Peter T Nelson
Journal:  Arch Pathol Lab Med       Date:  2017-05-03       Impact factor: 5.534

Review 8.  Progranulin, lysosomal regulation and neurodegenerative disease.

Authors:  Aimee W Kao; Andrew McKay; Param Priya Singh; Anne Brunet; Eric J Huang
Journal:  Nat Rev Neurosci       Date:  2017-04-24       Impact factor: 34.870

Review 9.  Management of frontotemporal dementia in mental health and multidisciplinary settings.

Authors:  Mary Anne Wylie; Adriana Shnall; Chiadi U Onyike; Edward D Huey
Journal:  Int Rev Psychiatry       Date:  2013-04

Review 10.  Behavioural interventions for enhancing life participation in behavioural variant frontotemporal dementia and primary progressive aphasia.

Authors:  Kathleen B Kortte; Emily J Rogalski
Journal:  Int Rev Psychiatry       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.